Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
1 other identifier
observational
700
1 country
1
Brief Summary
It is difficult to detect the intestinal protozoal infections among the HIV-infected persons or travelers diarrhea by using the traditional microscopy or staining methods. The purpose of this study aimed at finding out the appropriate diagnostic methods and the infection rate of the intestinal protozoa, including the Entamoeba, Cryptosporidium and Giardia among the HIV-infected persons by using the antigen detection method and biological method. The investigators also tried to analyze the associated HIV infection status and sexual transmitted diseases (STD) including Gonorrhea, Chlamydial trachomatis, Syphilis, Genital warts and Herpes simplex virus in this study. The study will collect the blood, urine and stool samples from 200 intravenous drug user (IDU) with HIV-infected in the prisons, 400 intravenous drug user (IDU) without HIV infected and 100 intravenous drug user (IDU) with HIV infected receiving methadone maintenance treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 19, 2008
CompletedFirst Posted
Study publicly available on registry
August 21, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJanuary 23, 2012
December 1, 2011
2.7 years
August 19, 2008
January 20, 2012
Conditions
Keywords
Study Arms (3)
HIDU
intravenous drug user (IDU) with HIV infected
IDU
intravenous drug user (IDU) without HIV
MH
persons receiving methadone maintenance treatment
Eligibility Criteria
The samples are obtained from Kaohsiung prison, Kaohsiung women's prison, Pingtung prison and the Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung, Taiwan.
You may qualify if:
- Clinical diagnosis of HIV
- Receiving Methadone Maintenance Treatment
- intravenous drug user (IDU)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaoshing Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2008
First Posted
August 21, 2008
Study Start
April 1, 2008
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
January 23, 2012
Record last verified: 2011-12